| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5693945 | European Urology | 2017 | 10 Pages |
Abstract
The metastatic assay may improve the ability to detect patients at risk of metastatic recurrence following radical prostatectomy. The impact of adjuvant therapies should be assessed in this higher-risk population.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Steven M. Walker, Laura A. Knight, Andrena M. McCavigan, Gemma E. Logan, Viktor Berge, Amir Sherif, Hardev Pandha, Anne Y. Warren, Catherine Davidson, Adam Uprichard, Jaine K. Blayney, Bethanie Price, Gera L. Jellema, Christopher J. Steele,